Autopsy report · NCT00997581

Apremilast Therapy for Acute Gouty Arthritis

“Colaborator withdrew support.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Dartmouth-Hitchcock Medical Center

Sponsor type

University, hospital or other

Conditions

Acute Gout

Interventions

apremilast; indomethacin SR

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes
  “Colloborator-Sponsor decision to terminate.” (59% match in meaning)
• Cognitive Effects of Bioavailable Curcumin
  “Sponsor withdrew.” (58% match in meaning)
• Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma
  “Sponsor withdrew support” (58% match in meaning)
• Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC
  “Grantor withdrew support due to slow accrual” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.